# 116-hr-6253: Crowdfunding to Combat the Coronavirus Act

116-hr-6253, Crowdfunding to Combat the Coronavirus Act, is a 116th Congress bill sponsored by Rep. McHenry, Patrick T. [R-NC-10] (R-NC); status Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/116-hr-6253
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 116-hr-6253
- Congress: 116
- Title: Crowdfunding to Combat the Coronavirus Act
- Status: Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced: 2020-03-12
- Sponsor: Rep. McHenry, Patrick T. [R-NC-10] (R-NC)
- Cosponsors: 4
- Policy area: Finance and Financial Sector
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Crowdfunding to Combat the Coronavirus Act This bill (1) establishes an award for the successful development of a vaccine for the coronavirus (i.e., the virus that causes COVID-19), and (2) extends specified Securities and Exchange Commission (SEC) registration exemptions to issuers of securities responding to the COVID-19 outbreak. The bill provides appropriations for the purpose of awarding&nbsp;a prize to the creator of a vaccine that (1) reduces the incidence and mortality rate of COVID-19 by more than 50%, and (2) is affordable and widely available to the public. Additionally, an issuer of securities that&nbsp;is developing a coronavirus vaccine, researching or producing medical equipment related to COVID-19, or researching or producing technology related to preventing the spread of COVID-19 may qualify for an exemption from SEC registration requirements&nbsp;regardless of the size of the issuer's offers&nbsp;or sales. Furthermore, these issuers are not subject to joint and several liability for certain claims. The provisions set forth in this bill expire the earlier of (1) the date the prize is awarded, or (2) three years after enactment. The Government Accountability Office must report on the bill's effects.

## Cosponsors (4)

- Rep. Wagner, Ann [R-MO-2] (R-MO), 2020-03-12T00:00:00.000Z
- Rep. Barr, Andy [R-KY-6] (R-KY), 2020-03-12T00:00:00.000Z
- Rep. Stivers, Steve [R-OH-15] (R-OH), 2020-03-12T00:00:00.000Z
- Rep. Huizenga, Bill [R-MI-4] (R-MI), 2020-03-12T00:00:00.000Z

## Related bills

- 116-hr-6269: Insured Depository Institution Business Continuity Planning Act of 2020
- 116-hr-6254: Gig Economy Infrastructure Act
- 116-hr-6252: Relief for Small Businesses Through Micro-Offerings Act of 2020
- 116-hr-6242: SEC Relief to Slow the Spread of Coronavirus Act of 2020
- 116-hr-6116: Consumer Financial Protection Commission Act
- 116-hr-4692: Countering Turkish Aggression Act of 2019

## Sources
- [116-hr-6253 on Congress.gov](https://www.congress.gov/bill/116th-congress/house-bill/6253)

## Related
- [116-hr-6269: Insured Depository Institution Business Continuity Planning Act of 2020](https://policyrisk.com/legislation/116-hr-6269)
- [116-hr-6254: Gig Economy Infrastructure Act](https://policyrisk.com/legislation/116-hr-6254)
- [116-hr-6252: Relief for Small Businesses Through Micro-Offerings Act of 2020](https://policyrisk.com/legislation/116-hr-6252)
- [116-hr-6242: SEC Relief to Slow the Spread of Coronavirus Act of 2020](https://policyrisk.com/legislation/116-hr-6242)
- [116-hr-6116: Consumer Financial Protection Commission Act](https://policyrisk.com/legislation/116-hr-6116)
- [116-hr-4692: Countering Turkish Aggression Act of 2019](https://policyrisk.com/legislation/116-hr-4692)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/116-hr-6253 (as of 2025-11-18).
